Chronic Kidney Disease Major Risk Factor for COVID-19 Severity and Mortality, A Scoping Review

被引：3

作者：

Einollahi, Behzad ^{[1
]}

Cegolon, Luca ^{[2
]}

Zhao, Shi ^{[3
]}

Ghadian, Alireza ^{[1
]}

Javanbakht, Mohammad ^{[1
]}

机构：

[1] Baqiyatallah Univ Med Sci, Nephrol & Urol Res Ctr, Tehran, Iran

[2] Local Hlth Unit N 2 Marca Trevigiana, Dept Publ Hlth, Treviso, Italy

[3] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China

来源：

IRANIAN JOURNAL OF KIDNEY DISEASES | 2021年 / 15卷 / 05期

关键词：

COVID-19; SARS-CoV-2; chronic kidney disease; HEMODIALYSIS; DYSFUNCTION; OUTCOMES;

D O I：

10.52547/ijkd.6797

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A growing body of evidence points out at chronic kidney disease (CKD) as a major risk factor for severe COVID-19, increasing also the respective mortality risk. Preventive measures, rapid monitoring organ function and interventions capable of preventing multiorgan failures are of great importance to reduce adverse outcomes in COVID-19 patients with CKD. While efforts are underway to carry out indirect protection interventions and large-scale vaccination to achieve herd immunity in the general population, direct protection of patients with CKD through rapid vaccination trials are necessary since uraemia and immunosuppressive agents could have a negative impact on vaccination responses of CDK patients. More epidemiological data are needed for in-depth understanding of the course and outcome of COVID-19 in CKD patients, supporting clinical decision-making.

引用

页码：323 / 326

页数：4